- Home
- USLM vs NVCR Comparison
USLM vs NVCR Comparison
Compare USLM & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- USLM
- NVCR
- Stock Information
- Founded
- USLM 1948
- NVCR 2000
- Country
- USLM United States
- NVCR Switzerland
- Employees
- USLM N/A
- NVCR 1488
- Industry
- USLM Other Metals and Minerals
- NVCR Medical/Dental Instruments
- Sector
- USLM Industrials
- NVCR Health Care
- Exchange
- USLM Nasdaq
- NVCR Nasdaq
- Market Cap
- USLM 3.6B
- NVCR 1.4B
- IPO Year
- USLM N/A
- NVCR 2015
- Fundamental
- Price
- USLM $129.66
- NVCR $12.72
- Analyst Decision
- USLM
- NVCR Buy
- Analyst Count
- USLM 0
- NVCR 7
- Target Price
- USLM N/A
- NVCR $28.79
- AVG Volume (30 Days)
- USLM 116.5K
- NVCR 1.3M
- Earning Date
- USLM 10-29-2025
- NVCR 10-29-2025
- Dividend Yield
- USLM 0.18%
- NVCR N/A
- EPS Growth
- USLM 44.81
- NVCR N/A
- EPS
- USLM 4.36
- NVCR N/A
- Revenue
- USLM $352,260,000.00
- NVCR $630,160,000.00
- Revenue This Year
- USLM $22.64
- NVCR $6.68
- Revenue Next Year
- USLM $8.38
- NVCR $7.01
- P/E Ratio
- USLM $29.06
- NVCR N/A
- Revenue Growth
- USLM 21.97
- NVCR 14.58
- 52 Week Low
- USLM $80.47
- NVCR $10.87
- 52 Week High
- USLM $159.53
- NVCR $34.13
- Technical
- Relative Strength Index (RSI)
- USLM 66.69
- NVCR 53.05
- Support Level
- USLM $119.42
- NVCR $11.98
- Resistance Level
- USLM $124.93
- NVCR $12.83
- Average True Range (ATR)
- USLM 3.57
- NVCR 0.56
- MACD
- USLM 0.15
- NVCR 0.16
- Stochastic Oscillator
- USLM 94.83
- NVCR 53.43
About USLM United States Lime & Minerals Inc.
United States Lime & Minerals Inc is engaged in the business of manufacturing lime and limestone products including PLS, quicklime, hydrated lime and lime slurry. It supplies its products predominantly to the construction (including highway, road, and building contractors), industrial (including paper and glass manufacturers), environmental (including municipal sanitation and water treatment facilities and flue gas treatment processes), metals (including steel producers), oil and gas services, roof shingle manufacturers and agriculture (including poultry and cattle feed producers) industries. The company operates through its Lime and Limestone Operations segment.
About NVCR NovoCure Limited
NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.